Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
- PMID: 21876150
- PMCID: PMC3179073
- DOI: 10.1073/pnas.1102999108
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
Abstract
There is increasing, but largely indirect, evidence pointing to an effect of commensal gut microbiota on the central nervous system (CNS). However, it is unknown whether lactic acid bacteria such as Lactobacillus rhamnosus could have a direct effect on neurotransmitter receptors in the CNS in normal, healthy animals. GABA is the main CNS inhibitory neurotransmitter and is significantly involved in regulating many physiological and psychological processes. Alterations in central GABA receptor expression are implicated in the pathogenesis of anxiety and depression, which are highly comorbid with functional bowel disorders. In this work, we show that chronic treatment with L. rhamnosus (JB-1) induced region-dependent alterations in GABA(B1b) mRNA in the brain with increases in cortical regions (cingulate and prelimbic) and concomitant reductions in expression in the hippocampus, amygdala, and locus coeruleus, in comparison with control-fed mice. In addition, L. rhamnosus (JB-1) reduced GABA(Aα2) mRNA expression in the prefrontal cortex and amygdala, but increased GABA(Aα2) in the hippocampus. Importantly, L. rhamnosus (JB-1) reduced stress-induced corticosterone and anxiety- and depression-related behavior. Moreover, the neurochemical and behavioral effects were not found in vagotomized mice, identifying the vagus as a major modulatory constitutive communication pathway between the bacteria exposed to the gut and the brain. Together, these findings highlight the important role of bacteria in the bidirectional communication of the gut-brain axis and suggest that certain organisms may prove to be useful therapeutic adjuncts in stress-related disorders such as anxiety and depression.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Comment in
-
Behaviour: 'Chillax' with probiotics.Nat Rev Neurosci. 2011 Sep 14;12(10):549. doi: 10.1038/nrn3115. Nat Rev Neurosci. 2011. PMID: 21915139 No abstract available.
-
Gut bacteria and brain function: the challenges of a growing field.Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):E175; author reply E176. doi: 10.1073/pnas.1118654109. Epub 2012 Jan 13. Proc Natl Acad Sci U S A. 2012. PMID: 22247293 Free PMC article. No abstract available.
-
Targeting the microbiota-gut-brain axis to modulate behavior: which bacterial strain will translate best to humans?Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):E174; author reply E176. doi: 10.1073/pnas.1118626109. Epub 2012 Jan 13. Proc Natl Acad Sci U S A. 2012. PMID: 22247294 Free PMC article. No abstract available.
References
-
- Bercik P, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010;139:2102–2112. - PubMed
-
- Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol Motil. 2011;23:187–192. - PubMed
-
- Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J. Mood and gut feelings. Brain Behav Immun. 2010;24:9–16. - PubMed
-
- Rousseaux C, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 2007;13:35–37. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical